Briacell Competitors and Similar CompaniesClear all
Briacell's competitors and similar companies include Olema Oncology and Myovant Sciences.
 Briacell Briacell is a clinical-stage biotech company that focuses on immuno-oncology and develops personalized immunotherapy for cancer. |  Olema Oncology Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers. |  Myovant Sciences Myovant Sciences is a biopharmaceutical company that focuses on women’s health and prostate cancer. | |
Founding Date | Founding Date 2004 | Founding Date 2007 | Founding Date 2016 |
Type | Type Public | Type Public | Type Subsidiary |
Tags | |||
Locations | Locations West Vancouver, CA HQ Berkeley, US New York, US | Locations San Francisco, US HQ San Francisco, US | Locations Brisbane, US HQ Basel, CH |
Employees | Employees 16 | Employees 9630% increase | Employees 1144% decrease |
Valuation ($) | Valuation ($) 30.2 m | Valuation ($) 679.2 m | Valuation ($) N/A |
Financial | |||
Net income | Net income ($26.6m) (FY, 2025) | Net income ($162.5m) (FY, 2025) | Net income ($206m) (FY, 2022) |
For sources of this data, please see the company profile
View Company Profiles
Olema Oncology
HQ
San Francisco, US
Employees
96↑ 30% increase
Olema Oncology (also known as Olema Pharmaceuticals) is a biopharmaceutical company focused on the discovery, development, and commercialization of targeted therapies for women’s cancers.
View companyMyovant Sciences
HQ
Brisbane, US
Myovant Sciences is a biopharmaceutical company that focuses on women’s health and prostate cancer.
View company